The evolution of radioembolisation
- PMID: 23026820
- DOI: 10.1016/S1470-2045(12)70370-4
The evolution of radioembolisation
Comment in
-
The evolution of radioembolisation.Lancet Oncol. 2012 Dec;13(12):e519. doi: 10.1016/S1470-2045(12)70484-9. Lancet Oncol. 2012. PMID: 23182192 No abstract available.
Comment on
-
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.Lancet Oncol. 2012 Oct;13(10):1025-34. doi: 10.1016/S1470-2045(12)70334-0. Epub 2012 Aug 22. Lancet Oncol. 2012. PMID: 22920685 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
